Suvretta-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
100
Total Value
2694889925
Accession Number
0001172661-25-002306
Form Type
13F-HR
Manager Name
Suvretta-Capital-Management
Data Enrichment
97% identified
97 identified3 unidentified

Holdings

100 positions • $2.7B total value
Manager:
Search and click to pin securities to the top
ABEONA THERAPEUTICS INC.
Shares:3.7M
Value:$17.5M
% of Portfolio:0.7% ($17.5M/$2.7B)
Erasca, Inc.
Shares:12.3M
Value:$16.9M
% of Portfolio:0.6% ($16.9M/$2.7B)
BIOGEN INC.
Shares:120.7K
Value:$16.5M
% of Portfolio:0.6% ($16.5M/$2.7B)
Caesars Entertainment, Inc.
Shares:652.5K
Value:$16.3M
% of Portfolio:0.6% ($16.3M/$2.7B)
Aura Biosciences, Inc.
Shares:2.7M
Value:$16.0M
% of Portfolio:0.6% ($16.0M/$2.7B)
UNITEDHEALTH GROUP INC
Shares:29.9K
Value:$15.7M
% of Portfolio:0.6% ($15.7M/$2.7B)
TAKE TWO INTERACTIVE SOFTWARE INC
Shares:72.4K
Value:$15.0M
% of Portfolio:0.6% ($15.0M/$2.7B)
Moderna, Inc.
Shares:517.2K
Value:$14.7M
% of Portfolio:0.5% ($14.7M/$2.7B)
Fulcrum Therapeutics, Inc.
Shares:5.1M
Value:$14.6M
% of Portfolio:0.5% ($14.6M/$2.7B)
GOLDMAN SACHS GROUP INC
Shares:25.5K
Value:$14.0M
% of Portfolio:0.5% ($14.0M/$2.7B)
Roblox Corp
Shares:227.7K
Value:$13.3M
% of Portfolio:0.5% ($13.3M/$2.7B)
Merck & Co., Inc.
Shares:144.1K
Value:$12.9M
% of Portfolio:0.5% ($12.9M/$2.7B)
Contineum Therapeutics, Inc.
Shares:1.7M
Value:$12.0M
% of Portfolio:0.4% ($12.0M/$2.7B)
PROKIDNEY CORP.
Shares:12.3M
Value:$10.8M
% of Portfolio:0.4% ($10.8M/$2.7B)
MOLECULAR PARTNERS AG
Shares:2.2M
Value:$8.6M
% of Portfolio:0.3% ($8.6M/$2.7B)
ABBOTT LABORATORIES
Shares:58.8K
Value:$7.8M
% of Portfolio:0.3% ($7.8M/$2.7B)
Monte Rosa Therapeutics, Inc.
Shares:1.6M
Value:$7.3M
% of Portfolio:0.3% ($7.3M/$2.7B)
Unity Software Inc.
Shares:339.6K
Value:$6.7M
% of Portfolio:0.2% ($6.7M/$2.7B)
InflaRx N.V.
Shares:6.5M
Value:$6.6M
% of Portfolio:0.2% ($6.6M/$2.7B)
Whitehawk Therapeutics, Inc.
Shares:3.7M
Value:$6.6M
% of Portfolio:0.2% ($6.6M/$2.7B)